CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
2.575
-0.006 (-0.25%)
Sep 17, 2025, 11:22 AM EDT - Market open
CollPlant Biotechnologies Market Cap
CollPlant Biotechnologies has a market cap or net worth of $32.74 million as of September 17, 2025. Its market cap has decreased by -43.96% in one year.
Market Cap
32.74M
Enterprise Value
24.15M
1-Year Change
-43.96%
Ranking
Category
Stock Price
$2.57
Market Cap Chart
Since May 14, 2015, CollPlant Biotechnologies's market cap has increased from $29.72M to $32.74M, an increase of 10.18%. That is a compound annual growth rate of 0.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 32.82M | -20.40% |
| Dec 31, 2024 | 41.24M | -43.65% |
| Dec 29, 2023 | 73.18M | -21.52% |
| Dec 30, 2022 | 93.25M | -46.69% |
| Dec 31, 2021 | 174.91M | 147.09% |
| Dec 31, 2020 | 70.79M | 129.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |